InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: rafunrafun post# 385305

Saturday, 08/06/2022 8:25:53 PM

Saturday, August 06, 2022 8:25:53 PM

Post# of 424560
r-

Zoey Becker is off ...

With the company’s sales presence in Germany suspended, Amarin finds itself in a tough spot as it wages on with the launch.

It is a technical suspension ... "we have suspended our contracted primary care field force to avoid having these resources becoming permanent, which was contractually scheduled to occur. ... we will very easily rebuild because we have the contacts of our teams and we can reinitiate that."

Amarin expects the reimbursement talks to wrap up in November.

Nope ... "by November or by end of this month" ... "on Germany, we are now in, I would say, the final stages of the negotiation with GKV with the payer. If those negotiations come -- we come to an agreement, then that would end maybe in a month or so. And if that doesn’t, then there is an additional opportunity for an arbitration that would take you until end of November."

It’s also working on launch plans for Sweden

Nope ... executing the plan ... "Sweden, where the work to obtain formulary status and launch is well underway." "Sweden and the UK are in launch mode"

Best,
G

Disclosure: I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for it.

Notice: This post is not investment advice, and not a recommendation to neither buy nor hold nor sell.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News